Received Mar 20, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
low grade fever; This non-serious case was reported by a consumer and described the occurrence of low grade fever in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced low grade fever (Verbatim: low grade fever). The outcome of the low grade fever was not reported. It was unknown if the reporter considered the low grade fever to be related to Shingrix. It was unknown if the company considered the low grade fever to be related to Shingrix. Additional Information: GSK Receipt Date: 12-MAR-2026 The batch number was not provided, and we are unable to contact the reporter.